CCR8+ Tregs are a stable subtype of Tregs with enhanced immunosuppressive properties (230), and in tumor sites where CCR8+ Tregs are plentiful imply the inferior prognosis (231, 233). This evidence concerns the gene CCR8 and neoplasm.